NUTRA PHARMA CORP (NPHC) Form 8-K Material Events
NUTRA PHARMA CORP (NPHC) is a publicly traded company on the OTC, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NPHC
CIK: 1119643
Exchange: OTC
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: CA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Astra Audit & Advisory, LLC
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerAlison Douglas
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-02 | 2026-08-21 | 8-K | 0001493152-26-041208 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-01 | — | SCHEDULE 13D Filing | 0001493152-26-041007 | View SEC Doc Filr Page |
| 3 | 2026-09-01 | 2026-08-21 | 3 | 0001493152-26-041005 | View SEC Doc Filr Page |
| 4 | 2026-09-01 | 2026-08-21 | 4 | 0001493152-26-041002 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001493152-26-039166 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-14 | 2026-06-30 | NT 10-Q | 0001493152-26-038022 | View SEC Doc Filr Page |
| 10-Q | 2026-05-29 | 2026-03-31 | 10-Q | 0001493152-26-026420 | View SEC Doc Filr Page |
| 10-K | 2026-05-20 | 2025-12-31 | 10-K | 0001493152-26-024641 | View SEC Doc Filr Page |
| 10-Q | 2026-04-06 | 2025-09-30 | 10-Q | 0001493152-26-015334 | View SEC Doc Filr Page |
| 10-Q | 2026-03-25 | 2025-06-30 | 10-Q | 0001493152-26-012625 | View SEC Doc Filr Page |
| 10-Q | 2026-03-11 | 2025-03-31 | 10-Q | 0001493152-26-009667 | View SEC Doc Filr Page |
| 10-K | 2026-02-17 | 2024-12-31 | 10-K | 0001493152-26-007044 | View SEC Doc Filr Page |
| 10-Q | 2026-01-02 | 2024-09-30 | 10-Q | 0001493152-26-000067 | View SEC Doc Filr Page |
| 10-Q | 2025-12-23 | 2024-06-30 | 10-Q | 0001493152-25-028946 | View SEC Doc Filr Page |
| 10-Q | 2025-12-17 | 2024-03-31 | 10-Q | 0001493152-25-028202 | View SEC Doc Filr Page |
| 10-K | 2025-11-24 | 2023-12-31 | 10-K | 0001493152-25-024800 | View SEC Doc Filr Page |
| 10-Q | 2025-10-28 | 2023-09-30 | 10-Q | 0001493152-25-019875 | View SEC Doc Filr Page |
| 10-Q | 2025-10-23 | 2023-06-30 | 10-Q | 0001493152-25-019037 | View SEC Doc Filr Page |
| 10-Q | 2025-10-16 | 2023-03-31 | 10-Q | 0001493152-25-018328 | View SEC Doc Filr Page |
| 10-K | 2025-09-03 | 2022-12-31 | 10-K | 0001641172-25-026446 | View SEC Doc Filr Page |
| 8-K | 2025-09-03 | 2024-03-27 | 8-K | 0001641172-25-026384 | View SEC Doc Filr Page |
| 8-K | 2024-03-22 | 2024-03-19 | 8-K Filing | 0001493152-24-010998 | View SEC Doc Filr Page |
| 10-Q | 2022-11-21 | 2022-09-30 | 10-Q Filing | 0001493152-22-033171 | View SEC Doc Filr Page |
| NT 10-Q | 2022-11-15 | 2022-09-30 | NT 10-Q Filing | 0001493152-22-032495 | View SEC Doc Filr Page |
| 10-Q | 2022-08-22 | 2022-06-30 | 10-Q Filing | 0001493152-22-023751 | View SEC Doc Filr Page |